APA (7th ed.) Citation

Thakur, M. D., Udyavar, A., Sandmann, T., Li, C., Bosch, L. J. W., O'Gorman, W., . . . Bourgon, R. (2018). 55PDIdentification of biological axes associated with stage II/III CRC recurrence risk and outcome after adjuvant therapy revealed a T-effector-independent prognostic role for granzyme B. Annals of Oncology, 29, N.PAG. https://doi.org/10.1093/annonc/mdy269.053

Chicago Style (17th ed.) Citation

Thakur, M Das, et al. "55PDIdentification of Biological Axes Associated with Stage II/III CRC Recurrence Risk and Outcome After Adjuvant Therapy Revealed a T-effector-independent Prognostic Role for Granzyme B." Annals of Oncology 29 (2018): N.PAG. https://doi.org/10.1093/annonc/mdy269.053.

MLA (9th ed.) Citation

Thakur, M Das, et al. "55PDIdentification of Biological Axes Associated with Stage II/III CRC Recurrence Risk and Outcome After Adjuvant Therapy Revealed a T-effector-independent Prognostic Role for Granzyme B." Annals of Oncology, vol. 29, 2018, p. N.PAG, https://doi.org/10.1093/annonc/mdy269.053.